Pancreatic β-cell (β-cell)

Pancreatic β-cells are specialized endocrine cells located in the islets of Langerhans in the pancreas that are essential for insulin production and secretion. They function as the body’s main glucose sensors, releasing insulin in response to elevated blood glucose and other metabolic cues. Insulin synthesis involves the conversion of preproinsulin to insulin and C-peptide, which is then stored and released via exocytosis triggered by increased intracellular ATP and calcium in response to glucose uptake. β-cell dysfunction—through apoptosis, loss of mass, or dedifferentiation—is central to the pathogenesis of both type 1 and type 2 diabetes, contributing to defective insulin secretion and metabolic disturbances. These cells are critical therapeutic targets in diabetes research, with drugs acting directly or indirectly to preserve, stimulate, or replace β-cell function and insulin output.

Other names

Islet β-cellBeta cellInsulin-producing cell

Sulfonylureas and meglitinides: Close ATP-sensitive potassium channels, leading to cell membrane depolarization, opening voltage-gated calcium channels, and stimulating insulin exocytosis. GLP-1 receptor agonists/DPP-4 inhibitors: Enhance glucose-dependent insulin secretion via incretin pathway. Thiazolidinediones: Improve β-cell function by reducing glucose toxicity and inflammation. Insulin therapy: Replaces insulin in patients with loss or dysfunction of β-cells.